The Therapeutic Goods Administration (TGA) of Australia has completed an upgrade of its internal Adverse Event Management System (AEMS) by transitioning the database to a secure cloud-based platform. This modernisation enhances the system’s performance, stability and data security, supporting key pharmacovigilance functions.

The upgraded platform delivers:

• Improved system stability for managing adverse event reports.
• Enhanced data security, helping protect sensitive safety information.
• A more responsive pharmacovigilance database to support regulators, sponsors, healthcare professionals and other stakeholders involved in medicine safety monitoring.

This upgrade reflects the TGA’s commitment to continuous improvement in safety surveillance infrastructure, and aims to ensure the database remains fit-for-purpose in supporting the monitoring of suspected adverse events associated with medicines.

For more information: Upgrade of TGA’s internal database for medicine adverse events reports